Lifevantage Corporation LFVN Business Segments
| TTM Q3 '26 | TTM Q2 '26 | TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Product | ||||||
| AXIO Product Line | $15.16M+5.9% | $15.62M+13.5% | $15.24M+12.3% | $15.31M+14.5% | $14.31M— | |
| Petandim Product Line | $1.97M-10.4% | $2.05M-8.3% | $2.06M-11.6% | $2.12M-11.7% | $2.19M— | |
| Phys IQ Product Line | $4.45M-6.0% | $4.97M+14.8% | $5.19M+29.4% | $5.1M+33.3% | $4.74M— | |
| Protandim | $86.03M-12.5% | $89.58M-11.1% | $93.19M-8.9% | $95.33M-8.5% | $98.27M-9.0% | |
| True Science Product Line | $39.34M-7.7% | $42.14M-6.3% | $45.03M-2.3% | $39.82M-29.2% | $42.63M— | |
| Revenue by Geography | ||||||
| JP | $24.98M+2.2% | $25.6M+4.8% | $25.6M+0.6% | $25.4M-5.9% | $24.44M-17.1% | |
| Other Foreign | $24.56M-0.6% | $24.7M-4.3% | $24.88M-6.4% | $24.69M-10.2% | $24.71M— | |
| US | $145.79M-15.9% | $159.75M-1.5% | $178.39M+23.8% | $178.44M+22.5% | $173.31M+17.5% | |
| Non-Current Assets by Geography | ||||||
| JP | $3.22M-58.2% | $5.06M-36.8% | $5.44M-36.3% | $5.77M-34.5% | $7.7M+6.4% | |
| Other Foreign | $821.8K— | —— | —— | —— | —— | |
| US | $34.18M-56.2% | $54.26M-30.8% | $53.84M-32.5% | $58.85M-28.4% | $78.04M-6.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Lifevantage Corporation break its business down?
- Lifevantage Corporation (LFVN) reports revenue by product across 7 parts — AXIO Product Line, Life Vantage Product Line, Love Biome Product Line, Petandim Product Line and Phys IQ Product Line. Each is extracted from the segment footnotes and tracked over time.
- Where does Lifevantage Corporation's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Lifevantage Corporation's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
